Private Wealth Partners’s GenMark Diagnostics, Inc GNMK Stock Holding History

Private Wealth Partners’s Portfolio GNMK Stock Details GNMK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-300,000	Closed	-$2.21M	–	119
2018 Q3	$2.21M	Sell	300,000 -70,000	-19%	-$514K	0.34%	59
2018 Q2	$2.36M	Buy	370,000 +70,000	+23%	+$463K	0.4%	59
2018 Q1	$1.63M	Buy	+300,000	New	+$1.49M	0.28%	62
2017 Q4	–	Sell	-50,000	Closed	-$481K	–	136
2017 Q3	$481K	Buy	+50,000	New	+$519K	0.1%	91

Other funds holding GNMK

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

CCM

Cadian Capital Management New York $821M AUM 14.36% 1-Year Est. Return

Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HighTower Advisors Chicago, Illinois $94.2B AUM 21.24% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Private Wealth Partners's GNMK Position: Q4 2018 in Review

Private Wealth Partners sold out of GenMark Diagnostics, Inc (GNMK) in Q4 2018, closing a stake of 300,000 shares — an estimated $2.21M sold.

Private Wealth Partners first reported a position in GNMK in Q3 2017 and held it in 4 quarters. The position peaked at $2.36M in Q2 2018. 103 funds tracked by Wall St. Rank hold GNMK as of Q4 2018.

Private Wealth Partners reported no remaining GenMark Diagnostics, Inc position as of Q4 2018 after selling out during the quarter.
Private Wealth Partners sold 300,000 GenMark Diagnostics, Inc shares in Q4 2018, an estimated $2.21M.
Private Wealth Partners first reported a position in GenMark Diagnostics, Inc in Q3 2017 and held it in 4 quarters.
Private Wealth Partners's GenMark Diagnostics, Inc position peaked at $2.36M in Q2 2018.
103 funds tracked by Wall St. Rank held GenMark Diagnostics, Inc as of Q4 2018.

Based on Private Wealth Partners's 13F filing for Q4 2018, filed 13 Feb 2019.